ABBV: abbvie.com Company Cash on Hand

Graphic logo of abbvie.com (ABBV)

AbbVie Inc. (ABBV) focuses on targeted therapy in oncology and immunology, utilizing M&A to refresh its portfolio. Risks are linked to the loss of exclusivity for key drugs, while growth is supported by robotic laboratories and data automation. Free cash flow demonstrates the liquidity of reserves, with 10.78 representing the current level of the metric, allowing for an assessment of the company's capital management efficiency.

ABBV - AbbVie Inc Company Liquid Assets over the range 07/04/2022 - 11/21/2026

Financial and market metric breakdowns for AbbVie (ABBV)

- stock quotes and analyst forecast:
- market capitalization information:
Basic company analysis:ABBV AbbVie
Product sample of abbvie.com

AbbVie Inc. (ABBV) successfully offsets generic pressure through the introduction of innovative drugs. The cash liquidity history visualizes daily cash balances, reflecting the business's actual solvency. This metric measures the absolute volume of liquid assets, allowing for an assessment of the balance between a financial safety cushion and capital efficiency. A stable cash reserve confirms the company's ability to fund R&D and maintain market leadership.